Processing

Please wait...

Settings

Settings

Goto Application

1. WO2009147439 - ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS

Publication Number WO/2009/147439
Publication Date 10.12.2009
International Application No. PCT/GB2009/050621
International Filing Date 04.06.2009
Chapter 2 Demand Filed 30.03.2010
IPC
A61K 31/353 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 31/05 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 45/06 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 35/00 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
CPC
A61K 31/05
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
05Phenols
A61K 31/352
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
A61K 31/353
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
335having oxygen as the only ring hetero atom, e.g. fungichromin
35having six-membered rings with one oxygen as the only ring hetero atom
352condensed with carbocyclic rings, e.g. cannabinols, methantheline
3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 35/00
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
35Antineoplastic agents
Applicants
  • GW PHARMA LIMITED [GB]/[GB] (AllExceptUS)
  • OTSUKA PHARMACEUTICAL CO LIMITED [JP]/[JP] (AllExceptUS)
  • VELASCO DIEZ, Guillermo [ES]/[ES] (UsOnly)
  • GUZMAN PASTOR, Manuel [ES]/[ES] (UsOnly)
  • LORENTE, Mar [ES]/[ES] (UsOnly)
  • TORRES, Sofia [ES]/[ES] (UsOnly)
  • RODRIGUEZ, Fatima [ES]/[ES] (UsOnly)
Inventors
  • VELASCO DIEZ, Guillermo
  • GUZMAN PASTOR, Manuel
  • LORENTE, Mar
  • TORRES, Sofia
  • RODRIGUEZ, Fatima
Agents
  • HARRISON GODDARD FOOTE
Priority Data
0810195.804.06.2008GB
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) ANTI-TUMOURAL EFFECTS OF CANNABINOID COMBINATIONS
(FR) EFFETS ANTI-TUMORAUX DE COMBINAISONS CANNABINOÏDES
Abstract
(EN)
The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).
(FR)
L'invention concerne l'utilisation d'une combinaison de cannabinoïdes, en particulier un tétrahydrocannabinol (THC) et un cannabidiol (CBD), pour produire un médicament utilisé pour traiter le cancer. Le cancer à traiter peut être, notamment une tumeur cérébrale, plus particulièrement un gliome et encore plus particulièrement un glioblastome multiforme (GBM).
Latest bibliographic data on file with the International Bureau